Pap Test Kit

Integrated kit combining sampling brush, preservation medium, and processing materials for comprehensive cervical cancer screening.

Liquid-based cytology reagent kit designed for Papanicolaou screening procedures. Used in preparation of cell samples for microscopic examination and diagnosis of cervical abnormalities.

Liquid-based cervical cytology kit for standardized preparation and preservation of cervical cell samples in screening and diagnostic applications. Designed for use with digital pathology systems and AI-assisted cytology analysis to improve diagnostic accuracy in cervical cancer detection programs.

Liquid-based cytology kit combined with HPV detection for cervical cancer screening. The system integrates morphological assessment with molecular HPV testing for comprehensive cervical dysplasia evaluation.

Single tube HPV detection kit for cervical cancer screening identifying 14 high-risk HPV types. Designed to satisfy cervical cytology screening requirements.

Sample collection kit designed for HPV testing procedures. Facilitates proper specimen collection and preservation for laboratory analysis of human papillomavirus detection.

Complete testing system for detection of disease markers, pathogens, or antibodies in patient specimens. Designed for use in clinical laboratories with documented sensitivity and specificity.

Single-tube HPV detection assay that identifies 14 high-risk HPV genotypes, satisfying cervical cytology screening requirements with streamlined testing methodology.

Testing system for perinatal disease screening and risk assessment in pregnant women and newborns. Supports maternal-fetal health monitoring protocols.

Molecular diagnostic test for detection and genotyping of human papillomavirus. Supports cervical cancer screening and HPV-related disease diagnosis.

Auxiliary diagnostic kit supporting cervical cancer detection through HPV genotyping and molecular analysis for comprehensive cancer risk assessment.

Molecular diagnostic test for human papillomavirus detection using polymerase chain reaction technology. Enables nucleic acid-based identification of HPV pathogens for clinical screening applications.